Page last updated: 2024-11-03

rabeprazole and Colitis

rabeprazole has been researched along with Colitis in 1 studies

Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.

Colitis: Inflammation of the COLON section of the large intestine (INTESTINE, LARGE), usually with symptoms such as DIARRHEA (often with blood and mucus), ABDOMINAL PAIN, and FEVER.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Son, M1
Park, IS1
Kim, S1
Ma, HW1
Kim, JH1
Kim, TI1
Kim, WH1
Han, J1
Kim, SW1
Cheon, JH1

Other Studies

1 other study available for rabeprazole and Colitis

ArticleYear
Novel Potassium-Competitive Acid Blocker, Tegoprazan, Protects Against Colitis by Improving Gut Barrier Function.
    Frontiers in immunology, 2022, Volume: 13

    Topics: Animals; Benzene Derivatives; Colitis; Dysbiosis; Imidazoles; Inflammation; Inflammatory Bowel Disea

2022